Fink Matthias A, Stoll Sibylle, Melzig Claudius, Steuwe Andrea, Partovi Sasan, Böckler Dittmar, Kauczor Hans-Ulrich, Rengier Fabian
Clinic for Diagnostic and Interventional Radiology, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany.
Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, 40225 Dusseldorf, Germany.
Diagnostics (Basel). 2022 Mar 10;12(3):675. doi: 10.3390/diagnostics12030675.
The purpose of this study was to prospectively analyse image quality and radiation dose of body mass index (BMI)-adapted low-radiation and low-iodine dose CTA of the thoracoabdominal aorta in obese and non-obese patients. This prospective, single-centre study included patients scheduled for aortic CTA between November 2017 and August 2020 without symptoms of high-grade heart failure. A BMI-adapted protocol was used: Group A/Group B, BMI < 30/≥ 30 kg/m2, tube potential 80/100 kVp, total iodine dose 14.5/17.4 g. Intraindividual comparison with the institutional clinical routine aortic CTA protocol was performed. The final study cohort comprised 161 patients (mean 71.1 ± 9.4 years, 32 women), thereof 126 patients in Group A (mean BMI 25.4 ± 2.8 kg/m2) and 35 patients in Group B (34.0 ± 3.4 kg/m2). Mean attenuation over five aortoiliac measurement positions for Group A/B was 354.9 ± 78.2/262.1 ± 73.0 HU. Mean effective dose for Group A/B was 3.05 ± 0.46/6.02 ± 1.14 mSv. Intraindividual comparison in 50 patients demonstrated effective dose savings for Group A/B of 34.4 ± 14.5/25.4 ± 14.1% (both p < 0.001), and iodine dose savings for Group A/B of 54/44.8%. Regression analysis showed that female sex and increasing age were independently associated with higher vascular attenuation. In conclusion, BMI-adapted, low-radiation and low-iodine dose CTA of the thoracoabdominal aorta delivers diagnostic image quality in non-obese and obese patients without symptoms of high-grade heart failure, with superior image quality in females and the elderly.
本研究旨在前瞻性分析肥胖和非肥胖患者中,根据体重指数(BMI)调整的低辐射和低碘剂量胸主动脉CT血管造影(CTA)的图像质量和辐射剂量。这项前瞻性单中心研究纳入了2017年11月至2020年8月期间计划进行主动脉CTA且无重度心力衰竭症状的患者。采用了根据BMI调整的方案:A组/B组,BMI<30/≥30kg/m²,管电压80/100kVp,总碘剂量14.5/17.4g。与机构临床常规主动脉CTA方案进行个体内比较。最终研究队列包括161例患者(平均71.1±9.4岁,32名女性),其中A组126例患者(平均BMI 25.4±2.8kg/m²),B组35例患者(34.0±3.4kg/m²)。A组/B组五个腹主动脉测量位置的平均衰减值为354.9±78.2/262.1±73.0HU。A组/B组的平均有效剂量为3.05±0.46/6.02±1.14mSv。50例患者的个体内比较显示,A组/B组的有效剂量节省了34.4±14.5/25.4±14.1%(均p<0.001),A组/B组的碘剂量节省了54/44.8%。回归分析表明,女性和年龄增长与血管衰减增加独立相关。总之,根据BMI调整的低辐射和低碘剂量胸主动脉CTA在无重度心力衰竭症状的非肥胖和肥胖患者中提供了诊断图像质量,女性和老年人的图像质量更佳。